{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:09:44Z","timestamp":1790636984797,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T00:00:00Z","timestamp":1469491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.nutres.2016.07.005","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T21:30:22Z","timestamp":1469741422000},"page":"1162-1170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Low daily dose of 3 mg monacolin K from RYR reduces the concentration of LDL-C in a randomized, placebo-controlled intervention"],"prefix":"10.1016","volume":"36","author":[{"given":"Tina","family":"Heinz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Philipp","family":"Schuchardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyman","family":"Hadji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nutres.2016.07.005_bb0005","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2147\/VHRM.S5684","article-title":"Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk","volume":"5","author":"Sharma","year":"2009","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.nutres.2016.07.005_bb0010","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(10)62038-7","article-title":"National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3\u00b70 million participants","volume":"9765","author":"Farzadfar","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.nutres.2016.07.005_bb0015","article-title":"Third report on the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report","volume":"3143-421","author":"NCEP III","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.nutres.2016.07.005_bb0020","doi-asserted-by":"crossref","first-page":"91G","DOI":"10.1016\/0002-9149(87)90165-2","article-title":"Coronary risk prediction in adults (the Framingham Heart study)","volume":"14","author":"Wilson","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nutres.2016.07.005_bb0025","first-page":"1267","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins","volume":"9493","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.nutres.2016.07.005_bb0030","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.nutres.2016.07.005_bb0035","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jacc.2005.05.085","article-title":"Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis","volume":"10","author":"Robinson","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nutres.2016.07.005_bb0040","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/ajcn\/71.2.472","article-title":"Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials","volume":"2","author":"Anderson","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nutres.2016.07.005_bb0045","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/jn\/131.9.2275","article-title":"A monounsaturated fatty acid\u2013rich pecan-enriched diet favorably alters the serum lipid profile of healthy men and women","volume":"9","author":"Rajaram","year":"2001","journal-title":"J Nutr"},{"key":"10.1016\/j.nutres.2016.07.005_bb0050","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1161\/01.ATV.0000120784.08823.99","article-title":"Plant sterol-fortified orange juice effectively lowers cholesterol levels in mildly hypercholesterolemic healthy individuals","volume":"3","author":"Devaraj","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nutres.2016.07.005_bb0055","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0011-393X(97)80063-X","article-title":"Multicenter clinical trial of the serum lipid-lowering effects of a monascus purpureus (red yeast) rice preparation from traditional chinese medicine","volume":"12","author":"Wang","year":"1997","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.nutres.2016.07.005_bb0060","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1021\/jf000338c","article-title":"Constituents of red yeast Rice, a traditional Chinese food and medicine","volume":"11","author":"Ma","year":"2000","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.nutres.2016.07.005_bb0065","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jnutbio.2007.05.012","article-title":"Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cells","volume":"7","author":"Hong","year":"2008","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.nutres.2016.07.005_bb0070","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/ajcn\/69.2.231","article-title":"Cholesterol-lowering effects of a proprietary Chinese red-yeast rice dietary supplement","volume":"2","author":"Heber","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nutres.2016.07.005_bb0075","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/eje.1.02012","article-title":"Efficacy and safety of Monascus Purpureus went rice in subjects with hyperlipidemia","volume":"5","author":"Lin","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.nutres.2016.07.005_bb0080","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.amjcard.2008.02.056","article-title":"Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction","volume":"12","author":"Lu","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nutres.2016.07.005_bb0085","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/HJR.0b013e32801da137","article-title":"Efficacy of Monascus Purpureus went rice on lowering lipid ratios in hypercholesterolemic patients","volume":"3","author":"Huang","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.nutres.2016.07.005_bb0090","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.nutres.2013.05.015","article-title":"Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects","volume":"8","author":"Cicero","year":"2013","journal-title":"Nutr Res"},{"key":"10.1016\/j.nutres.2016.07.005_bb0095","volume":"7","author":"EFSA Panel","year":"2011","journal-title":"EFSA J"},{"key":"10.1016\/j.nutres.2016.07.005_bb0100","article-title":"Efficacy of a red yeast rice based nutraceutical in large subgroups of hypercholesterolemic subjects in every day clinical practice","volume":"239-46","author":"Cicero","year":"2010","journal-title":"Med J Nutrition Metab"},{"key":"10.1016\/j.nutres.2016.07.005_bb0105","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.nut.2016.01.012","article-title":"ESSENS dyslipidemia: a placebo-controlled, randomized study of a nutritional supplement containing red yeast rice in subjects with newly diagnosed dyslipidemia","volume":"7\u20138","author":"Kasliwal","year":"2016","journal-title":"Nutrition"},{"key":"10.1016\/j.nutres.2016.07.005_bb0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacl.2013.11.003","article-title":"Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid plus","volume":"1","author":"Ruscica","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.nutres.2016.07.005_bb0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.phanu.2013.02.003","article-title":"Nutraceutical combination (red yeast rice, berberine and policosanols) improves aortic stiffness in low-moderate risk hypercholesterolemic patients","volume":"2","author":"Pirro","year":"2013","journal-title":"PharmaNutrition"},{"key":"10.1016\/j.nutres.2016.07.005_bb0120","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.numecd.2009.05.017","article-title":"Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study","volume":"9","author":"Affuso","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.nutres.2016.07.005_bb0125","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","article-title":"Plasma homocysteine as a risk factor for vascular disease. The European concerted action project","author":"Graham","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.nutres.2016.07.005_bb0130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/01.CIR.102.6.605","article-title":"Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes","volume":"6","author":"Stubbs","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.nutres.2016.07.005_bb0135","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.nutres.2016.07.005_bb0140","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"13","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.nutres.2016.07.005_bb0145","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.clnu.2012.12.009","article-title":"Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: a meta-analysis of randomized controlled trials","volume":"5","author":"Qin","year":"2013","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nutres.2016.07.005_bb0150","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"15","author":"B\u00f8naa","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nutres.2016.07.005_bb0155","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jama.300.7.795","article-title":"Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial","volume":"7","author":"Ebbing","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.nutres.2016.07.005_bb0160","first-page":"2486","article-title":"Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial","volume":"24","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.nutres.2016.07.005_bb0165","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2796.1995.tb01190.x","article-title":"Plasma homocysteine-lowering effect of folic acid","volume":"4","author":"Landgren","year":"1995","journal-title":"J Intern Med"},{"key":"10.1016\/j.nutres.2016.07.005_bb0170","article-title":"Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers","volume":"356-61","author":"den Heijer","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nutres.2016.07.005_bb0175","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/sj.ejcn.1601388","article-title":"Assessment of three levels of folic acid on serum folate and plasma homocysteine: a randomised placebo-controlled double-blind dietary intervention trial","volume":"8","author":"Venn","year":"2002","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.nutres.2016.07.005_bb0180","doi-asserted-by":"crossref","first-page":"830","DOI":"10.7326\/0003-4819-150-12-200906160-00006","article-title":"Red yeast Rice for dyslipidemia in statin-intolerant patients","volume":"12","author":"Becker","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nutres.2016.07.005_bb0185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/14017431003624123","article-title":"HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study","volume":"4","author":"Bogsrud","year":"2010","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.nutres.2016.07.005_bb0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/107555301750164181","article-title":"An analysis of nine proprietary Chinese red yeast Rice dietary supplements: implications of variability in chemical profile and contents","volume":"2","author":"Heber","year":"2001","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.nutres.2016.07.005_bb0195","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/01.CIR.0000139985.81163.CE","article-title":"Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease","volume":"8","author":"Zhao","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.nutres.2016.07.005_bb0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ctim.2005.07.008","article-title":"Antihyperlipidaemic effect of a Monascus Purpureus brand dietary supplement on a large sample of subjects at low risk for cardiovascular disease: a pilot study","volume":"4","author":"Cicero","year":"2005","journal-title":"Complement Ther Med"},{"key":"10.1016\/j.nutres.2016.07.005_bb0205","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjcard.2009.08.672","article-title":"Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance","volume":"2","author":"Halbert","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nutres.2016.07.005_bb0210","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1472-6882-13-178","article-title":"Red yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial","volume":"13","author":"Verhoeven","year":"2013","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.nutres.2016.07.005_bb0215","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jacl.2014.09.002","article-title":"Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study","volume":"6","author":"Moriarty","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.nutres.2016.07.005_bb0220","doi-asserted-by":"crossref","first-page":"852","DOI":"10.7164\/antibiotics.32.852","article-title":"Monacolin K, a new hypo-cholesterolemic agent produced by a monascus species","volume":"8","author":"Endo","year":"1979","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.nutres.2016.07.005_bb0225","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jpba.2004.04.004","article-title":"Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry","volume":"5","author":"Li","year":"2004","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.nutres.2016.07.005_bb0230","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ajcn\/69.1.30","article-title":"Cholesterol-lowering effects of dietary fiber: a meta-analysis","volume":"1","author":"Brown","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nutres.2016.07.005_bb0235","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ajcn\/76.6.1272","article-title":"Unesterified plant sterols and stanols lower LDL-cholesterolconcentrations equivalently in hypercholesterolemic persons","volume":"6","author":"Vanstone","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nutres.2016.07.005_bb0240","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11883-010-0145-0","article-title":"The role of red yeast rice for the physician","volume":"1","author":"Gordon","year":"2011","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.nutres.2016.07.005_bb0245","first-page":"192","article-title":"Antiatherogenic, hepatoprotective, and hypolipidemic effects of coenzyme Q10 in alloxan-induced type 1 diabetic rats","volume":"10","author":"Ahmadvand","year":"2014","journal-title":"ARYA Atheroscler"},{"key":"10.1016\/j.nutres.2016.07.005_bb0250","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/iub.388","article-title":"The reduced form of coenzyme Q10 mediates distinct effects on cholesterol metabolism at the transcriptional and metabolite level in SAMP1 mice","volume":"11","author":"Schmelzer","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.nutres.2016.07.005_bb0255","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/2008-7802.162461","article-title":"Beneficial effects of coenzyme Q10 supplementation on lipid profile and Intereukin-6 and intercellular adhesion molecule-1 reduction, preliminary results of a double-blind trial in acute myocardial infarction","volume":"6","author":"Mohseni","year":"2015","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.nutres.2016.07.005_bb0260","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2337\/dc08-1736","article-title":"Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients","volume":"5","author":"Hamilton","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nutres.2016.07.005_bb0265","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.2337\/dc08-0118","article-title":"Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction","volume":"8","author":"Chew","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nutres.2016.07.005_bb0270","first-page":"894","article-title":"Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials","volume":"7135","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.nutres.2016.07.005_bb0275","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1365-2362.2006.01739.x","article-title":"High- but not low-dose folic acid improves endothelial function in coronary artery disease","volume":"12","author":"Moat","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.nutres.2016.07.005_bb0280","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/ajcn\/69.1.99","article-title":"Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial","volume":"69","author":"Brouwer","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nutres.2016.07.005_bb0285","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000046683","article-title":"Homocysteine-lowering effect of 500 \u03bcg folic acid every other day versus 250 \u03bcg\/day","volume":"44","author":"Brouwer","year":"2000","journal-title":"Ann Nutr Metab"}],"container-title":["Nutrition Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531716302317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531716302317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T22:07:42Z","timestamp":1568239662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0271531716302317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0271531716302317"],"URL":"https:\/\/doi.org\/10.1016\/j.nutres.2016.07.005","relation":{},"ISSN":["0271-5317"],"issn-type":[{"value":"0271-5317","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low daily dose of 3 mg monacolin K from RYR reduces the concentration of LDL-C in a randomized, placebo-controlled intervention","name":"articletitle","label":"Article Title"},{"value":"Nutrition Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nutres.2016.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}